Maxim Sanzhakov

Dr. Maxim Sanzhakov


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
ETElena G. Tikhonova
Elena G. Tikhonova
MSMaxim Sanzhakov
Maxim Sanzhakov
YTYulia Tereshkina
Yulia Tereshkina
LKLyubov Kostryukova
Lyubov Kostryukova
YKYuliya Khudoklinova
Yuliya Khudoklinova
OIOlga M. Ipatova
Olga M. Ipatova
One of the current trends in modern pharmaceuticals is the supply of drugs by transport systems. The use of delivery systems allows to increase the therapeutic efficacy, tolerability, and safety of drug therapy. Liposomes, polymer nanoparticles, carbon nanoparticles, blood cells, metal nanoparticles, oxides, etc., are used as transport systems. This work is aimed at obtaining a finished technological product based on soy phospholipids with particle size in the nanometer range and reproducible characteristics (size, charge). For this purpose, we carried out investigations to select the optimal conditions of technological process. The developed technology makes it possible to obtain phospholipid nanoparticles without the use of any solubilizers and/or surfactants, which increases its practical relevance for further work. The versatility of the technology is demonstrated by the example of incorporation of drugs of various chemical nature and pharmacotherapeutic groups.

8 November 2022 in Processes
Verified
Journal Article
Open access
PDF file
LALyubov Agafonova
Lyubov Agafonova
ETElena Tikhonova
Elena Tikhonova
MSMaxim Sanzhakov
Maxim Sanzhakov
LKLyubov Kostryukova
Lyubov Kostryukova
Victoria Vasilyevna ShumyantsevaVictoria Vasilyevna Shumyantseva
Victoria Vasilyevna Shumyantseva
The effect of phospholipid nanoparticles with different contents of phosphatidylcholine (PhNP80 and PhNP100) on dsDNA was studied by means of the electrochemical method. Changes in the electrochemical behavior of heterocyclic bases guanine, adenine and thymine in the range of potentials of 0.2–1.2 V in the presence of PhNPs were used for the assessment of the binding mechanism of the ligand–DNA interaction. Comparative analysis of the effect of PhNPs with different contents of phosphatidylcholine showed a more pronounced effect on the dsDNA of the PhNP100 nanosystem. From the obtained experimental data on the decrease in the amplitude of the nucleobases’ electrochemical oxidation currents, the electrochemical coefficient of the toxic effect was calculated as the ratio of the electrooxidation currents of dsDNA and dsDNA in the presence of phospholipid nanoparticles. PhNP80/100 (up to 11.4 mg/mL) does not influence dsDNA, PhNP80/100 (14.3–28.5 mg/mL) has a moderate toxic effect on dsDNA, PhNP80/100 at concentrations above 28.5 mg/mL already have a toxic effect, significantly reducing the maximum amplitude of the heterocyclic bases’ electrochemical oxidation current. Peak potentials of electrochemical oxidation of nucleobases did not shift in the presence of PhNP80 and PhNP100 (in the concentration range of 2.3–42.2 mg/mL), which could be possible through a groove-binding mode of phospholipid nanoparticle interaction with dsDNA.

1 October 2021 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
MSMaxim Sanzhakov
Maxim Sanzhakov
VKVasily A. Kudinov
Vasily A. Kudinov
KBKonstantin Konstantinovich Baskaev
Konstantin Konstantinovich Baskaev
GMG.E. Morozevich
G.E. Morozevich
DSD.S. Stepanova
D.S. Stepanova
ETE.G. Tikhonova
E.G. Tikhonova
Gold nanoparticles and their conjugates have significant potential in the field of diagnosis of various diseases due to their SPR, which enhances light scattering and absorption. Conjugates of gold nanoparticles with various ligands can be used for imaging biomolecules or detecting malignant neoplasms at an early stage. This study focuses on the construction of composite (or hybrid) phospholipid-gold nanoparticles using soy phosphatidylcholine and a targeted ligand (folic acid derivative) to attach specific targeting properties. According to the method of dynamic light scattering, the diameter of the obtained nanoparticles was less than 100 nm, the results of the MTT test indicated their moderate cytotoxicity. In vitro and in vivo experiments showed a significant increase in the accumulation of phospholipid-gold nanoparticles with a targeted fragment compared to those without a targeted fragment both in HeLa cells and in a tumor (in BDF mice with an injected LLC tumor). The resulting nanoparticles are suitable for specific delivery into tumor cells and visualization of various malignant neoplasms, including at early stages, due to the increased expression of the folate receptor characteristic of cells of a wide range of tumors.

25 July 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
ETElena G. Tikhonova
Elena G. Tikhonova
YTYulia Tereshkina
Yulia Tereshkina
LKLyubov Kostryukova
Lyubov Kostryukova
YKYuliya Khudoklinova
Yuliya Khudoklinova
MSMaxim Sanzhakov
Maxim Sanzhakov
MKMikhail A. Kiselev
Mikhail A. Kiselev
Nonsteroidal anti-inflammatory drugs (NSAIDs), inhibitors of cyclooxygenase-2, an enzyme involved in the formation of anti-inflammatory prostaglandin PGE2, are the most common treatment for chronic inflammatory diseases, such as, for example, arthritis. One of the most commonly used drugs of this class is indomethacin, a derivative of indolylacetic acid. In this work, we studied the physicochemical properties of the phospholipid composition of indomethacin obtained earlier (codenamed “Indolip”) and the effect of freeze drying on its parameters. It was shown that the properties such as particle size, light transmission, phospholipid oxidation index did not change significantly, which indicated the stability of the drug after lyophilization. Measurement of the spectra of small-angle neutron scattering has shown that morphologically, Indolip is a vesicle whose radius is five times greater than the value of the bilayer thickness.

12 May 2022 in Preprints.org
Verified
Preprint
Open access
PDF file
KZKonstantin Zolotarev
Konstantin Zolotarev
AMAnton N. Mikhailov
Anton N. Mikhailov
VNValeriya I. Nakhod
Valeriya I. Nakhod
MSMaxim Sanzhakov
Maxim Sanzhakov
ETElena G. Tikhonova
Elena G. Tikhonova
MMMarina V. Mikhailova
Marina V. Mikhailova
Silicon nanoparticles (SiNPs) are highly promising for biological and biomedical applications, including bioimaging, due to their unique opltical properties (i.e. strong fluorescence and very high photostability). Their low or negligible in vitro toxicity has been reported, but in vivo toxicity and biological effects of SiNPs are still uncertain. Uncoated SiNPs were dispersed in distilled water via sonication, and their rapid aggregation was observed (319.0 ± 2.4 nm particle size). In vivo toxicity was studied using Danio rerio embryos and larvae. Rapid aggregation in their incubation medium was observed; besides that, SiNPs at 25 mg/L or higher concentration induced swim bladder malformation and/or death of the fish. The estimated LC50 value for 7-day larvae was 180 mg/L. This is the first in vivo toxicity study of uncoated and unfunctionalized SiNPs. To achieve better stability in biological media and lower toxicity, SiNPs should be covered with hydrophilic layers, but their absorption by cellular membranes may be weaker in this case.